Resultados de búsqueda - Xiaojing Lin
- Mostrando 1 - 2 Resultados de 2
-
1
Preclinical and first-in-human of purinostat mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed/refractory multiple myeloma and lymphoma por Linyu Yang, Qiang Qiu, Jie Wang, Yi Wen, He Li, Rui Liang, Yunyu Feng, Fang Wang, Xiaojing Lin, Minghai Tang, Jianhong Yang, Heying Pei, Peng Zhao, Jishi Wang, Jin Xiang, Jia Miao, Li Zheng, Ke Tan, Yongsheng Wang, Yiguo Hu, Lijuan Chen, Weili Zhao, Ting Niu
Publicado 2025-06-01Abstract Simultaneously targeting key pathogenic drivers and remodeling of the tumor microenvironment represents a critical therapeutic strategy for relapsed or refractory (r/r) multiple myeloma (MM) and lymphoma. Purinostat mesylate (PM), a highly selective HDAC I/II binhibitor, exhibits excellent...
Enlace del recurso
Artículo -
2
Medium-band Astrophysics with the Grism of NIRCam In Frontier Fields (MAGNIF): Spectroscopic Census of Hα Luminosity Functions and Cosmic Star Formation at z ∼ 4.5 and 6.3 por Shuqi Fu, Fengwu Sun, Linhua Jiang, Xiaojing Lin, Jose M. Diego, Lukas J. Furtak, Mathilde Jauzac, Anton M. Koekemoer, Mingyu Li, Masamune Oguri, Nency R. Patel, Christopher N. A. Willmer, Rogier A. Windhorst, Adi Zitrin, Franz E. Bauer, Chian-Chou Chen, Wenlei Chen, Cheng Cheng, Christopher J. Conselice, Daniel J. Eisenstein, Eiichi Egami, Daniel Espada, Xiaohui Fan, Seiji Fujimoto, Tiger Yu-Yang Hsiao, Xiangyu Jin, Kotaro Kohno, David J. Lagattuta, Zihao Li, Weizhe Liu, Jordi Miralda-Escudé, Yuanhang Ning, Sandro Tacchella, Wei Leong Tee, Hideki Umehata, Feige Wang, Haojing Yan, Yongda Zhu
Publicado 2025-01-01We measure H α luminosity functions (LFs) at redshifts z ∼ 4.5 and 6.3 using the JWST Medium-band Astrophysics with the Grism of NIRCam In Frontier fields (MAGNIF) survey. MAGNIF obtained NIRCam grism spectra with the F360M and F480M filters in four Frontier Fields. We identify 248 H α emitters bas...
Enlace del recurso
Artículo